Read an article in Research Futures about the CSMB, featuring an interview with President Phil Hieter:
As scientists make fast and concerted advancements in life-saving technologies, the squeeze on funding could threaten their momentum.
That’s where Dr Philip Hieter, President of the Canadian Society for Molecular Biosciences (CSMB), comes in. To get the ‘biggest bang for their buck’, the CSMB is leveraging its collective knowledge and talents by focusing on the most pressing issues facing fundamental research, like funding. Through advocacy and education, they aim to influence not only present and future scientists, but decision makers in the Canadian government and the world.
CSMB establishes new Board committee structure and appoints At-Large members
Following a call for applications to apply for At-Large member positions in the committees of the CSMB Board in October, the new committee structure mandated by the Board of Directors was completed.
The At-Large members that were selected were Julie Claycomb and Jim Woodgett (Advocacy and Communication), Peter Stirling (Membership and Diversity), Imogen Coe ( Finance and Development ), Esther Verheyen ( Awards ), Sarah Hughes ( Conferences ), Bill Stanford ( Nominations ), Senthill Kumar, Erin Kennedy and MacKenzie Lawrence (Trainee ). The At-Large members will have two year terms, and another round will be added in the fall of 2018 such that one At-large committee member will be cycled on, and one off, on an annual basis in subsequent years.